Iloprost Power 15 in Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Pulmonary Arterial Hypertension
Related studies linked through entity extraction aliases.
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)
- Status
- TERMINATED
- Phase
- N/A
Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.
- Status
- UNKNOWN
- Phase
- PHASE4
Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan
- Status
- WITHDRAWN
- Phase
- PHASE4
Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
- Status
- WITHDRAWN
- Phase
- PHASE4
Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans
- Status
- COMPLETED
- Phase
- N/A
Pulmonary Arterial Hypertension in Systemic Sclerosis
- Status
- UNKNOWN
- Phase
- N/A
Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)
- Status
- COMPLETED
- Phase
- PHASE4
The Early Recognition of Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- NA
Pharmacogenomics in Pulmonary Arterial Hypertension
- Status
- WITHDRAWN
- Phase
- N/A
Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202)
- Status
- COMPLETED
- Phase
- PHASE3
Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)
- Status
- COMPLETED
- Phase
- NA
A Study to Evaluate GSK1325760A - a Long-Term Extension Study
- Status
- COMPLETED
- Phase
- PHASE3
Rehabilitation for Patients With Pulmonary Arterial Hypertension
- Status
- UNKNOWN
- Phase
- NA
Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension
- Status
- TERMINATED
- Phase
- PHASE4